January 7, 2025 - 16:44
The FDA has released new guidance addressing the use of artificial intelligence (AI) in drug development, emphasizing the potential risks associated with this rapidly evolving technology. The agency warns that improper use of AI could lead to life-threatening consequences, underscoring the critical need for early engagement between sponsors and regulators.
In the guidance, the FDA calls for sponsors to provide comprehensive information about the development and maintenance of AI models. This includes detailed documentation of the algorithms used, data sources, and validation processes. By ensuring transparency and thorough communication, the FDA aims to mitigate risks and enhance the safety and efficacy of AI-driven drug development.
The agency's proactive stance reflects a growing recognition of the complexities and challenges posed by AI technologies in healthcare. As AI continues to play an increasingly prominent role in the pharmaceutical industry, the FDA's guidance serves as a crucial framework for navigating its potential pitfalls while fostering innovation.
July 30, 2025 - 04:37
Marvell Technology Sees Stock Surge Following AI Collaboration AnnouncementShares of networking chip designer Marvell Technology experienced a notable increase of 3.3% during the morning trading session. This surge follows the announcement of a strategic collaboration...
July 29, 2025 - 12:36
New Software Can Assess Sleep Deprivation in the WorkplaceA groundbreaking technology has emerged that can determine if employees are suffering from sleep deprivation, potentially impacting their ability to operate heavy machinery or drive large vehicles...
July 28, 2025 - 23:54
BioFlyte Partners with Pittsburgh International Airport to Enhance Aerosol DetectionPittsburgh International Airport (PIT) has reached a significant milestone in its xBridge innovation program by entering a five-year partnership with BioFlyte, a pioneering company specializing in...
July 28, 2025 - 06:09
Globetronics Technology Bhd Faces Challenges Amid Mixed FundamentalsGlobetronics Technology Bhd (KLSE:GTRONIC) has encountered a difficult period recently, with its share price experiencing a notable decline of 15% over the past three months. Investors are...